Annaida develops microMRS, a non-invasive platform to measure intracellular metabolism in living samples. In IVF, it enables embryo viability assessment without biopsy, improving selection beyond morphology. The technology extends to biofluid-based fertility profiling and is already deployed in research labs for high-sensitivity metabolic analysis. With applications across clinical IVF and life sciences research, Annaida addresses a large, fast-growing global market.